Updated risk models demonstrate low risk of symptomatic radionecrosis following stereotactic radiosurgery for brain metastases

Abstract

These results compare favorably with the QUANTEC brain tolerance estimates for radiosurgery, providing optimism for lower toxicity in the modern era. Additional studies are needed to determine dose tolerance parameters across a broad spectrum of patients.